NASDAQ · STOCK
Cigna
$293.32
52W $239.51 – $315.47
63/100
$77.19B
12.3
0.32
Price History (6M)
Executive Summary
7 analysts weighed in with 71% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Overall recommendation: BUY.
Bull & Bear Case
Bull Case
- Positive MACD histogram signals bullish momentum.
- Bullish candlestick pattern(s) detected: Hammer, Three White Soldiers.
- Bullish candlestick patterns signal potential reversal or continuation of upside.
- Daily volatility (ATR%) above ~3% is treated as elevated risk.
Bear Case
- Stochastic RSI (100.0) confirms overbought conditions.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
63/100
Agreement
71%
Analysts
7
Conviction
Moderate
Value Analyst
bullish
70
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 12.3 is inexpensive for the broad market
Growth Analyst
neutral
45
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ EPS growing 30.5% YoY
− 4 consecutive earnings misses -- execution concerns
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
neutral
52
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− Current ratio of 0.85 is tight -- limited short-term liquidity cushion
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 21 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
65.8
Neutral
MACD Histogram
1.174
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$291.55
Resistance
$296.14
Bollinger %B
0.79
Inside Bands
Price vs Moving Averages
EMA 9
$287.26
Above
EMA 21
$285.62
Above
EMA 50
$284.09
Above
EMA 200
$284.60
Above
Fundamental Analysis
Valuation
98
Growth
54
Profitability
32
Financial Health
46
Valuation
P/E Ratio
12.3×
P/B Ratio
1.76×
PEG Ratio
—
Dividend Yield
2.14%
52W High
$315.47
52W Low
$239.51
Quality & Growth
ROE
1516.0%
ROA
405.0%
Gross Margin
915.0%
Operating Margin
344.0%
Revenue Growth YoY
+882.0%
Debt / Equity
0.75
AI Fundamental Assessment
P/E ratio of 12.3 (inexpensive relative to a 15-40x range); Price-to-book of 1.8x; Revenue growth (YoY) of 8.8%; EPS growth (YoY) of 30.5%; Return on equity of 15.2%; Return on assets of 4.0%; Net margin of 2.3%; Gross margin of 9.2%; Current ratio of 0.85 (tight short-term liquidity); Debt-to-equity of 0.75; Most recent quarter missed estimates by 0.7%; 4 consecutive earnings misses; EPS growth decelerating (+3.2% -> -3.6% QoQ); Analyst estimates flat over recent quarters
Key Risks
- Stochastic RSI (100.0) confirms overbought conditions.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full CI Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile